Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Biopharm - Innovators In Regenerative Medicine: |
Description | SYMBIOSIS offers a comprehensive range of analytical methods and services to meet your drug substance and drug product development |
Keywords | SYMBIOSIS, analytical methods, GMP, GLP, Bioassay, N-terminale Sequenzierung, Stabilitätsprüfung, Proteinanalytik, Antikörperanalytik, Freigabeprüfung, MALDI TOF MS, Arzneibuchmethoden, NADA, Residual DNA, CE, Ph.Eur., N-terminal sequencing |
WebSite | biopharm.de |
Host IP | 213.172.99.74 |
Location | Germany |
Site | Rank |
arktisbiopharma.de | 11,932,645 |
arktisbiopharma.ch | 35,799,767 |
arktisbiopharma.academy | 20,044,800 |
arktisbiopharmadev.de | 0 |
Euro€4,408
Zuletzt aktualisiert: 2022-07-20 00:19:13
biopharm.de hat Semrush globalen Rang von 6,795,538. biopharm.de hat einen geschätzten Wert von € 4,408, basierend auf seinen geschätzten Werbeeinnahmen. biopharm.de empfängt jeden Tag ungefähr 551 einzelne Besucher. Sein Webserver befindet sich in Germany mit der IP-Adresse 213.172.99.74. Laut SiteAdvisor ist biopharm.de sicher zu besuchen. |
Kauf-/Verkaufswert | Euro€4,408 |
Tägliche Werbeeinnahmen | Euro€116,261 |
Monatlicher Anzeigenumsatz | Euro€39,121 |
Jährliche Werbeeinnahmen | Euro€2,755 |
Tägliche eindeutige Besucher | 551 |
Hinweis: Alle Traffic- und Einnahmenwerte sind Schätzungen. |
Host | Type | TTL | Data |
biopharm.de. | A | 300 | IP: 213.172.99.74 |
biopharm.de. | NS | 300 | NS Record: ns2.mk.de. |
biopharm.de. | NS | 300 | NS Record: ns1.mk.de. |
biopharm.de. | MX | 300 | MX Record: 10 mx2.mk.de. |
biopharm.de. | MX | 300 | MX Record: 10 mx3.mk.de. |
biopharm.de. | MX | 300 | MX Record: 10 mx1.mk.de. |
biopharm.de. | MX | 300 | MX Record: 10 mx4.mk.de. |
biopharm.de. | TXT | 300 | TXT Record: v=spf1 a a:biofw.biopharm.de ip4:80.153.58.50 include:_spf.mk.de ~all |
Events Downloads Home Company Mission History Management Contact Growth Factor Platform Wound healing Osteoporosis Maxillo-facial Degenerative disc disease Fracture Healing Parkinson disease Erectile dysfunction Osteoarthritis Licensing / Partnering IP Partner Publications Fracture Healing Growth factor mutant BB-1 mediated enhanced reconstruction of long bone architecture combining positive features of previously used growth factors. READ MORE Parkinson disease Thanks to its Growth-Factor platform, Biopharm has shown that rhGDF-5 protects nigrostriatal dopaminergic neurons in vivo. Advantage of intranasal delivery bypasses the blood-brain barrier READ MORE Maxillo-facial The product line MD05 has been developed as a novel regenerative bone substitute material related to dentistry for dental implantology and surgical treatment of periodontal disease. READ MORE Wound Healing Regenerative Wound Dressing: Efficient treatment of superficial skin lesions (e.g. diabetic ulcer, burns) in |
HTTP/1.1 307 Temporary Redirect Date: Wed, 03 Nov 2021 15:22:24 GMT Server: Apache X-Powered-By: PHP/7.3.29 Upgrade: h2,h2c Connection: Upgrade Location: http://biopharm.de/index.php?id=257 Content-Type: text/html; charset=UTF-8 HTTP/1.1 200 OK Date: Wed, 03 Nov 2021 15:22:24 GMT Server: Apache X-Powered-By: PHP/7.3.29 Content-Language: en Content-Length: 13761 Content-Type: text/html; charset=utf-8 |